WALPHARMA
ActiveSummary
WALPHARMA has been active since 1990 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags). The 2024 annual accounts show equity of €98,407 and a net result of -€27,936. Equity is shrinking by about 19% per year across the filed financial years. Its solvency ranks better than 64% of 25,572 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- WALPHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, Article 2 - SIEGE” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Avec ou sans limitation de durée, TITRE IV : Administration – Contrôle” (deed in French)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Article 10 – CESSION/TRANSMISSIONS D’ACTIONS, descendant en ligne directe sans agrément, devient de plein droit actionnaire au décès auteur” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 21 June at 14:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Assemblée générale, formes prévues pour modifications aux statuts” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Peut désigner un ou plusieurs liquidateurs et déterminer pouvoirs et émoluments, si aucun autre liquidateur désigné” (deed in French)